GlaxoSmithKline Pharmaceuticals Limited (GLAXO) — Working Capital to Net Assets Ratio
GlaxoSmithKline Pharmaceuticals Limited (GLAXO) has a Working Capital to Net Assets ratio of 76.0% as of September 2025. Working capital of Rs12.98 Billion (current assets of Rs29.71 Billion minus current liabilities of Rs16.74 Billion) is measured against net assets of Rs17.08 Billion. A higher ratio indicates strong short-term liquidity financed by the equity base. See GlaxoSmithKline Pharmaceuticals Limited (GLAXO) net asset quality to measure how much of total assets are equity-financed.
WC/NA Ratio
Working Capital
Current Assets
Current Liabilities
GlaxoSmithKline Pharmaceuticals Limited Working Capital to Net Assets (2005–2025)
This chart shows how GlaxoSmithKline Pharmaceuticals Limited's Working Capital to Net Assets ratio has evolved across 21 annual periods from 2005 to 2025. As of September 2025, the ratio stands at 76.0%, reflecting working capital of Rs12.98 Billion against net assets of Rs17.08 Billion INR. Check tangible net worth ratio of GlaxoSmithKline Pharmaceuticals Limited to evaluate the tangible quality of the company's equity base.
Annual Working Capital to Net Assets for GlaxoSmithKline Pharmaceuticals Limited (2005–2025)
The table below presents the year-by-year Working Capital to Net Assets ratio for GlaxoSmithKline Pharmaceuticals Limited from 2005 to 2025, covering 21 annual filings. Each row shows current assets, current liabilities, working capital, net assets, the ratio, and the change in percentage points compared to the prior year. For live market cap and the full company profile, see GLAXO stock market capitalisation.
| Year | WC/NA Ratio | Working Capital (INR) | Net Assets | Current Assets | Current Liabilities | Change (pp) |
|---|---|---|---|---|---|---|
| 2025 | 77.1% | Rs15.05 Billion | Rs19.51 Billion | Rs34.10 Billion | Rs19.05 Billion | ▲ +5.5 pp |
| 2024 | 71.6% | Rs12.73 Billion | Rs17.78 Billion | Rs27.98 Billion | Rs15.25 Billion | ▲ +4.6 pp |
| 2023 | 67.1% | Rs11.68 Billion | Rs17.41 Billion | Rs24.94 Billion | Rs13.26 Billion | ▼ -8.4 pp |
| 2022 | 75.5% | Rs20.10 Billion | Rs26.63 Billion | Rs37.08 Billion | Rs16.98 Billion | ▲ +18.9 pp |
| 2021 | 56.6% | Rs8.48 Billion | Rs14.99 Billion | Rs22.03 Billion | Rs13.55 Billion | ▲ +15.3 pp |
| 2020 | 41.2% | Rs7.51 Billion | Rs18.21 Billion | Rs17.75 Billion | Rs10.24 Billion | ▲ +15.4 pp |
| 2019 | 25.8% | Rs5.52 Billion | Rs21.40 Billion | Rs20.06 Billion | Rs14.54 Billion | ▼ -2.5 pp |
| 2018 | 28.3% | Rs5.82 Billion | Rs20.57 Billion | Rs21.81 Billion | Rs16.00 Billion | ▼ -19.2 pp |
| 2017 | 47.5% | Rs9.52 Billion | Rs20.07 Billion | Rs16.73 Billion | Rs7.20 Billion | ▼ -18.3 pp |
| 2016 | 65.7% | Rs11.15 Billion | Rs16.96 Billion | Rs21.72 Billion | Rs10.58 Billion | ▼ -19.2 pp |
| 2015 | 84.9% | Rs20.74 Billion | Rs24.44 Billion | Rs25.74 Billion | Rs5.00 Billion | ▼ -2.3 pp |
| 2014 | 87.2% | Rs17.35 Billion | Rs19.90 Billion | Rs26.24 Billion | Rs8.89 Billion | ▼ -3.0 pp |
| 2013 | 90.2% | Rs18.10 Billion | Rs20.07 Billion | Rs26.47 Billion | Rs8.36 Billion | ▲ +5.4 pp |
| 2012 | 84.8% | Rs16.42 Billion | Rs19.36 Billion | Rs27.61 Billion | Rs11.19 Billion | ▼ -0.5 pp |
| 2011 | 85.3% | Rs16.65 Billion | Rs19.52 Billion | Rs25.10 Billion | Rs8.45 Billion | ▲ +2.2 pp |
| 2010 | 83.1% | Rs14.84 Billion | Rs17.86 Billion | Rs21.83 Billion | Rs6.99 Billion | ▲ +37.3 pp |
| 2009 | 45.8% | Rs7.22 Billion | Rs15.76 Billion | Rs14.52 Billion | Rs7.30 Billion | ▲ +51.1 pp |
| 2008 | -5.3% | Rs-730.84 Million | Rs13.81 Billion | Rs5.67 Billion | Rs6.40 Billion | ▼ -1.2 pp |
| 2007 | -4.1% | Rs-492.62 Million | Rs12.05 Billion | Rs5.19 Billion | Rs5.68 Billion | ▲ +4.1 pp |
| 2006 | -8.2% | Rs-779.11 Million | Rs9.53 Billion | Rs4.69 Billion | Rs5.46 Billion | ▼ -11.3 pp |
| 2005 | 3.2% | Rs292.01 Million | Rs9.24 Billion | Rs5.00 Billion | Rs4.71 Billion | — |